OP-1 GUT METATRANSCRIPTOMICS AND METABOLOMICS REVEAL ASSOCIATION OF CYSTEINE AND PURINE METABOLISMS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD)

OP-1 GUT METATRANSCRIPTOMICS AND METABOLOMICS REVEAL ASSOCIATION OF CYSTEINE AND PURINE METABOLISMS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD)

Background: The gut microbiome represents a niche for biomarkers discovery to risk-stratify MAFLD patients. However, each population may have unique microbiome signatures and studies are needed in Latin America where MAFLD prevalence and severity are high. Aims: To identify gut metatranscriptome and...

Full description

Bibliographic Details
Main Authors: Noelia Mazzini Flavia, Florencia Mascardi María, Ruda Vera M., Shilpa Pandit, Leandra Mansur, Yanqun Wang, Gounarides John, Cook Frank, Sebastián Marciano, Leila Haddad, Jesica Tamaroff Ana, Paola Casciato, Adrián Narvaez, Margarita Anders, Federico Orozco, Susana Gutt, Adrián Gadano, Celia Méndez García, Martin Marro, Alberto Penas Steinhardt, Julieta Trinks
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268121002155

Internet

http://www.sciencedirect.com/science/article/pii/S1665268121002155

Similar Items